22.626 articles found

Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.

Avanzi M, Uber E, Bonfà F.

Neurol Sci · 2004-06-01

DOI: 10.1007/s10072-004-0238-zPMID: 15221629

Combining growth factors, stem cells, and gene therapy for the aging brain.

Behrstock S, Svendsen CN.

Ann N Y Acad Sci · 2004-06-01

DOI: 10.1196/annals.1297.002PMID: 15246984

Olanzapine for delirium in parkinsonism: therapeutic benefits in lieu of adverse consequences.

Gupta N, Sharma P, Prabhakar S.

Neurol India · 2004-06-01

PMID: 15269501

Physiotherapy in Parkinson's disease: utilisation and patient satisfaction.

Keus SH, Bloem BR, Verbaan D, de Jonge PA, Hofman M, van Hilten BJ, Munneke M.

J Neurol · 2004-06-01

DOI: 10.1007/s00415-004-0402-7PMID: 15311343

Functional surgery for Parkinson's disease treatment: a structured analysis of a decade of published literature.

Boucai L, Cerquetti D, Merello M.

Br J Neurosurg · 2004-06-01

DOI: 10.1080/02688690410001732625PMID: 15327220

[Development and application of gene therapy technologies].

Ozawa K.

Uirusu · 2004-06-01

DOI: 10.2222/jsv.54.49PMID: 15449904

Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease.

Chan PL, Nutt JG, Holford NH.

J Pharmacokinet Pharmacodyn · 2004-06-01

DOI: 10.1023/b:jopa.0000039566.75368.59PMID: 15518246

Combined therapy for the treatment of Parkinson's disease

DI PAOLO THERESE.

· 2004-05-28

Combined therapy for the treatment of Parkinson's disease

DI PAOLO THERESE.

· 2004-05-28

COMBINED THERAPY FOR THE TREATMENT OF PARKINSON'S DISEASE

DI PAOLO THERESE.

· 2004-05-28

SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE.

CORINNA SUNDERMANN.

· 2004-05-28

Treatment of neurodegenerative disease through intracranial delivery of siRNA

KAEMMERER WILLIAM F.

· 2004-05-25